Safety and discontinuation rate of immune checkpoint inhibitors used in patients with solid and hematological malignancies. A population based retrospective analysis.

Alaa ShahbarMajed AlshamraniMohammed AseeriTurki AlfayeaAbdelmajid Alnatsheh

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

Immune checkpoint inhibitors were well tolerated in the majority of our patient population with a comparable rate of immunerelated adverse effects in comparison to the published data. Corticosteroids were fundamentally used to treat immune-related adverse effects.

Keyphrases

case report
electronic health record
big data
randomized controlled trial
data analysis
artificial intelligence
clinical evaluation